The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics, Inc. | COM | 00461U105 | 8,618,965 | 1,258,243 | SH | SOLE | 1,258,243 | 0 | 0 | ||
Compass Therapeutics, Inc. | COM | 20454B104 | 2,456,545 | 1,246,977 | SH | SOLE | 1,246,977 | 0 | 0 | ||
Disc Medicine, Inc. | COM | 254604101 | 11,440,241 | 243,513 | SH | SOLE | 243,513 | 0 | 0 | ||
Hims & Hers Health, Inc. | COM CL A | 433000106 | 23,482,966 | 3,733,381 | SH | SOLE | 3,733,381 | 0 | 0 | ||
Kinnate Biopharma Inc. | COM | 49705R105 | 4,936,340 | 3,525,957 | SH | SOLE | 3,525,957 | 0 | 0 | ||
Pharvaris N.V. | COM | N69605108 | 691,674 | 33,142 | SH | SOLE | 33,142 | 0 | 0 | ||
Theseus Pharmaceuticals, Inc. | COM | 88369M101 | 11,052,661 | 4,108,796 | SH | SOLE | 4,108,796 | 0 | 0 |